Patent · US Active

Protease inhibitors

US10329266B2 · kind B2 · utility

0Cited by

7References

2Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Lourdes Salvador ODEN · Huddinge, SE
Magnus Nilsson · Mölndal, SE
Pia Kahnberg · Huddinge, SE
Bertil Samuelsson · Huddinge, SE
Urszula Grabowska · Huddinge, SE

Key dates

Filing date	Mar 30, 2018
Grant date	Jun 25, 2019
Priority date	—
Expiry date	Mar 30, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula II: wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.